Tuba Çandar

416 total citations
54 papers, 307 citations indexed

About

Tuba Çandar is a scholar working on Pulmonary and Respiratory Medicine, Obstetrics and Gynecology and Molecular Biology. According to data from OpenAlex, Tuba Çandar has authored 54 papers receiving a total of 307 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Pulmonary and Respiratory Medicine, 13 papers in Obstetrics and Gynecology and 10 papers in Molecular Biology. Recurrent topics in Tuba Çandar's work include Pregnancy and preeclampsia studies (9 papers), Gestational Diabetes Research and Management (5 papers) and Cancer-related Molecular Pathways (4 papers). Tuba Çandar is often cited by papers focused on Pregnancy and preeclampsia studies (9 papers), Gestational Diabetes Research and Management (5 papers) and Cancer-related Molecular Pathways (4 papers). Tuba Çandar collaborates with scholars based in Türkiye, United States and Norway. Tuba Çandar's co-authors include Gamze Sinem Çağlar, Nuran Allı, Selda Demırtaş, İrem Doğan, Neslihan Akdoğan, Turan Turhan, Canan Topçuoğlu, Hatice Kansu-Celik, Yasemin Taşçı and Deniz Baklacı and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Medicine.

In The Last Decade

Tuba Çandar

50 papers receiving 300 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Tuba Çandar Türkiye 10 75 59 47 46 41 54 307
Haorong Wu China 11 105 1.4× 27 0.5× 90 1.9× 12 0.3× 54 1.3× 28 342
Niloufar Torkamani Australia 9 35 0.5× 18 0.3× 51 1.1× 42 0.9× 21 0.5× 17 310
Nancy Martínez‐Rodríguez Mexico 12 81 1.1× 11 0.2× 46 1.0× 19 0.4× 23 0.6× 43 339
Ayumi Saito Japan 11 53 0.7× 16 0.3× 42 0.9× 65 1.4× 59 1.4× 45 370
M. H. Carstensen Germany 9 39 0.5× 52 0.9× 132 2.8× 30 0.7× 19 0.5× 23 424
Andy Joe Seelam United States 7 80 1.1× 23 0.4× 98 2.1× 7 0.2× 34 0.8× 8 324
Jason A. Collett United States 11 99 1.3× 11 0.2× 52 1.1× 8 0.2× 26 0.6× 25 383
Hee Dong Chae South Korea 11 45 0.6× 53 0.9× 31 0.7× 7 0.2× 14 0.3× 27 326
Ran Li China 11 61 0.8× 14 0.2× 54 1.1× 8 0.2× 27 0.7× 41 295
Christopher Denton United States 9 37 0.5× 7 0.1× 15 0.3× 40 0.9× 16 0.4× 30 327

Countries citing papers authored by Tuba Çandar

Since Specialization
Citations

This map shows the geographic impact of Tuba Çandar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tuba Çandar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tuba Çandar more than expected).

Fields of papers citing papers by Tuba Çandar

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tuba Çandar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tuba Çandar. The network helps show where Tuba Çandar may publish in the future.

Co-authorship network of co-authors of Tuba Çandar

This figure shows the co-authorship network connecting the top 25 collaborators of Tuba Çandar. A scholar is included among the top collaborators of Tuba Çandar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tuba Çandar. Tuba Çandar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Başaran, Mustafa, et al.. (2023). Serum galectin‑3 and α‑1‑acid glycoprotein levels in diagnosis and prognosis of idiopathic sudden sensorineural hearing loss. Experimental and Therapeutic Medicine. 25(3). 122–122. 1 indexed citations
2.
3.
Uzunlar, Özlem, et al.. (2022). Does alpha-1-acid glycoprotein determine for infertility in polycystic ovary syndrome?. European Journal of Obstetrics & Gynecology and Reproductive Biology. 274. 155–159. 2 indexed citations
4.
Taşçı, Yasemin, et al.. (2021). Do follicular fluid advanced glycation end products levels affect the ovarian response in unexplained infertility?. Gynecological Endocrinology. 37(9). 802–806. 3 indexed citations
5.
Çandar, Tuba, et al.. (2021). The role of serum podocalyxin levels in recurrent pregnancy loss. European Journal of Obstetrics & Gynecology and Reproductive Biology. 260. 114–117.
6.
Çandar, Tuba, et al.. (2021). The effect of folate on ischemia/reperfusion injury in a rat adnexal torsion model. Archives of Gynecology and Obstetrics. 303(6). 1495–1500. 8 indexed citations
7.
Uzunlar, Özlem, et al.. (2021). The effects of water immersion and epidural analgesia on cellular immune response, neuroendocrine, and oxidative markers. TURKISH JOURNAL OF MEDICAL SCIENCES. 51(3). 1420–1427. 2 indexed citations
8.
Kansu-Celik, Hatice, et al.. (2020). Myo-inositol oxygenese activity in second trimester of pregnancy: altered myoinositol catabolism in gestational diabetes mellitus. Archives of Physiology and Biochemistry. 128(4). 910–913. 4 indexed citations
9.
Tohma, Yusuf Aytaç, et al.. (2019). Serum ischemia modified albumin and endometrial cancer: a prospective case-control study. European Journal of Gynaecological Oncology. 40(3). 384–388. 1 indexed citations
10.
Akdoğan, Neslihan, et al.. (2019). Assessment of metabolic profile and ischemia-modified albumin level in patients with alopecia areata: A case–control study. Indian Journal of Dermatology. 64(1). 12–12. 17 indexed citations
11.
Hayran, Yıldız, et al.. (2019). Association of CYP2J2 polymorphism with susceptibility to psoriasis in Turkish population: a case–control study. Anais Brasileiros de Dermatologia. 95(1). 25–31. 2 indexed citations
12.
Tokmak, Aytekin, et al.. (2019). Evaluation of Serum Human Epididymis Protein 4 Levels in Women with Polycystic Ovary Syndrome. Cureus. 11(9). e5736–e5736. 2 indexed citations
13.
Kansu-Celik, Hatice, et al.. (2018). Maternal serum advanced glycation end products level as an early marker for predicting preterm labor/PPROM: a prospective preliminary study. The Journal of Maternal-Fetal & Neonatal Medicine. 32(16). 2758–2762. 16 indexed citations
14.
Çağlar, Gamze Sinem, Tolga Taşçı, Tuba Çandar, et al.. (2018). Pro-Gastrin Releasing Peptide: A New Serum Marker for Endometrioid Adenocarcinoma. Gynecologic and Obstetric Investigation. 83(6). 540–545. 6 indexed citations
15.
Doğan, İrem, et al.. (2018). Potential effects of metformin in DNA BER system based on oxidative status in type 2 diabetes. Biochimie. 154. 62–68. 33 indexed citations
16.
Doğan, İrem, et al.. (2018). Do MCF7 cells cope with metformin treatment under energetic stress in low glucose conditions?. Molecular Biology Reports. 45(3). 195–201. 2 indexed citations
17.
Akdoğan, Neslihan, et al.. (2018). Visfatin and insulin levels and cigarette smoking are independent risk factors for hidradenitis suppurativa: a case–control study. Archives of Dermatological Research. 310(10). 785–793. 26 indexed citations
18.
Çandar, Tuba, et al.. (2016). Plasma Glycated Albumin Levels Clearly Detect Hearing Loss and Atherosclerosis in Patients with Impaired Fasting Glucose. Medical Principles and Practice. 25(4). 309–315. 4 indexed citations
19.
Pabuçcu, Emre, et al.. (2016). Does maternal hydronephrosis have an impact on urinary neutrophil gelatinase-associated lipocalin (uNGAL) levels?. The Journal of Maternal-Fetal & Neonatal Medicine. 30(6). 717–721. 3 indexed citations
20.
Çağlar, Gamze Sinem, et al.. (2015). The association between ischemia modified albumin and placental histopathology in uncomplicated term deliveries. Placenta. 36(9). 1056–1058. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Haorong Wu Breakdown of academic impact, for papers by Niloufar Torkamani Breakdown of academic impact, for papers by Nancy Martínez‐Rodríguez Breakdown of academic impact, for papers by Ayumi Saito Breakdown of academic impact, for papers by M. H. Carstensen Breakdown of academic impact, for papers by Andy Joe Seelam Breakdown of academic impact, for papers by Jason A. Collett Breakdown of academic impact, for papers by Hee Dong Chae Breakdown of academic impact, for papers by Ran Li Breakdown of academic impact, for papers by Christopher Denton
Rankless by CCL
2026